#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	18870	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2133	878.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1424	1424	C	1125	C	1053	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	18870	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2133	878.1	0	HET	.	.	.	C1512T	.	1512	1512	C	1752	1752	C	987	C,T	744,190	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33924	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3796	891.7	0	.	n	.	0	T695C	SNP	695	695	T	1265	1265	C	1001	C	952	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33924	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3796	891.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1907	1907	A	1225	A	1164	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33924	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3796	891.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2541	2541	C	1077	C,T	1004,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33924	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3796	891.7	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3167	3167	T	1052	T	1010	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33924	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3796	891.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2615	2615	A	1061	A	1016	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	V36A	NONSYN	106	108	GTG	570	572	GCG	296;296;295	G;C;G	268;272;272	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	612	614	CGG	269;264;264	C;G;G	257;251;253	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	S68L	NONSYN	202	204	TCG	666	668	TTG	220;219;215	T;T;G	195;203;196	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	A90V	NONSYN	268	270	GCG	732	734	GTT	211;213;214	G;T;T	205;197;205	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	I105V	NONSYN	313	315	ATT	777	779	GTT	205;201;202	G;T;T	194;185;192	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	N125T	NONSYN	373	375	AAT	837	839	ACC	213;213;213	A;C;C	201;201;207	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	R135C	NONSYN	403	405	CGT	867	869	TGT	241;244;239	T;G;T	208;225;214	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	K151E	NONSYN	451	453	AAA	915	917	GAA	213;215;215	G;A;A	203;205;207	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	T152N	NONSYN	454	456	ACC	918	920	AAC	211;215;216	A;A;C	204;205;207	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	A172T	NONSYN	514	516	GCG	978	980	ACA	213;217;215	A;C;A	199;208;202	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	A175E	NONSYN	523	525	GCG	987	989	GAA	225;226;228	G;A;A	214;215;217	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	E176T	NONSYN	526	528	GAA	990	992	ACC	223;224;225	A;C;C	207;215;214	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	I178V	NONSYN	532	534	ATC	996	998	GTC	223;223;222	G;T;C	212;212;213	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	I188T	NONSYN	562	564	ATA	1026	1028	ACG	238;237;234	A;C;G	220;225;222	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	P200N	NONSYN	598	600	CCC	1062	1064	AAC	235;236;239	A;A;C	227;225;232	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1122	1124	TTG	241;240;239	T;T;G	222;219;218	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1179	1181	ACC	205;204;204	A;C;C	192;192;192	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1182	1184	GAC	203;204;203	G;A;C	190;185;190	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1191	1193	GCG	223;221;221	G;C,A,G;G	209;167,2,1;205	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1227	1229	GCT	196;195;193	G;C;T	182;184;179	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2376	folP	858	858	91.61	folP.l15.c30.ctg.1	1688	140.2	1	SNP	p	R230S	1	.	.	688	690	AGC	1152	1154	AGC	246;250;242	A;G;C	227;230;227	folP.Neisseria_meningitidis_H44_76_v1_00541:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	7340	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3410	214.6	1	SNP	p	S91F	0	.	.	271	273	TCC	575	577	TCC	240;240;241	T;C;C	229;226;227	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	7340	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3410	214.6	1	SNP	p	D95G	0	.	.	283	285	GAC	587	589	GAC	234;233;233	G,A;A;C	221,1;219;217	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	7340	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3410	214.6	1	SNP	p	D95N	0	.	.	283	285	GAC	587	589	GAC	234;233;233	G,A;A;C	221,1;219;217	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	2234	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1397	159.4	1	SNP	p	G45D	1	.	.	133	135	GAC	540	542	GAC	291;292;294	G;A;C	275;270;277	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1218	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c17.ctg.1	980	123.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6980	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3173	219.4	1	SNP	p	D86N	0	.	.	256	258	GAC	701	703	GAC	304;305;307	G,A;A;C	279,1;282;287	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6980	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3173	219.4	1	SNP	p	S87W	0	.	.	259	261	AGT	704	706	AGT	307;308;309	A;G;T	286;292;285	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6980	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3173	219.4	1	SNP	p	S87I	0	.	.	259	261	AGT	704	706	AGT	307;308;309	A;G;T	286;292;285	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6980	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3173	219.4	1	SNP	p	S87R	0	.	.	259	261	AGT	704	706	AGT	307;308;309	A;G;T	286;292;285	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6980	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3173	219.4	1	SNP	p	S88P	0	.	.	262	264	TCC	707	709	TCC	309;309;309	T;C;C	287;289;289	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	6162	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2719	226.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1543	1545	GGC	314;307;307	G;G;C	297;292;286	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	5208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2387	217.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1257	1259	GCA	304;306;304	G;C,G;A	286;281,1;288	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	5208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2387	217.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1260	1262	ATC	299;295;298	A;T,C,A;C	288;279,1,1;283	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	5208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2387	217.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1272	1274	GTG	288;286;287	G;T,G;G	274;271,1;272	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	5208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2387	217.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1272	1274	GTG	288;286;287	G;T,G;G	274;271,1;272	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	5208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2387	217.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1776	1778	ACC	267;265;271	A;C;C	246;253;258	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	5208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2387	217.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1830	1832	GCG	270;270;269	G;C;G	241;227;235	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	5208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2387	217.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1830	1832	GCG	270;270;269	G;C;G	241;227;235	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	5208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2387	217.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1953	1955	GGC	206;204;202	G,A;G;C	192,1;191;192	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	5208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2387	217.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1962	1964	GGC	198;201;200	G;G;C	185;187;181	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	5208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2387	217.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1980	1982	CCG	167;167;162	C,G;C;G	132,5;132;129	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6962	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3101	223.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3216	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1744	183.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	498	498	C	221	C,G	203,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	G38E	NONSYN	112	114	GGA	316	318	GAA	293;291;289	G;A;A	279;278;278	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	E48G	NONSYN	142	144	GAA	346	348	GGA	301;301;306	G;G;A	292;293;296	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	T87A	NONSYN	259	261	ACT	463	465	GCT	311;313;322	G;C;T	295;302;308	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	T89S	NONSYN	265	267	ACC	469	471	AGC	322;321;328	A;G;C	311;309;310	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	.	MULTIPLE	358	359	AA	561	562	CG	291;291	C;G	269;266	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	.	MULTIPLE	361	362	GA	564	566	CAG	285;278;279	C;A;G,A	260;256;257,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	N122K	NONSYN	364	366	AAC	568	570	AAA	281;277;275	A,G;A;A	262,1;260;256	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	K143E	NONSYN	427	429	AAA	631	633	GAA	259;261;267	G;A;A	250;250;256	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	V151A	NONSYN	451	453	GTA	655	657	GCA	278;279;281	G;C;A	265;263;261	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	N212D	NONSYN	634	636	AAT	838	840	GAT	287;287;284	G;A;T	270;272;269	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	D213G	NONSYN	637	639	GAT	841	843	GGT	281;278;276	G;G;T	269;267;259	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	I218M	NONSYN	652	654	ATA	856	858	ATG	271;270;270	A,G;T;G	259,1;259;256	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	T256A	NONSYN	766	768	ACA	970	972	GCA	262;261;261	G;C;A	250;249;252	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	W257T	NONSYN	769	771	TGG	973	975	ACG	259;263;266	A;C;G	249;254;257	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	R258G	NONSYN	772	774	CGT	976	978	GGG	265;267;267	G;G;G	255;257;255	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	A259V	NONSYN	775	777	GCT	979	981	GTT	266;266;267	G;T;T	258;251;259	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1039	1041	GTA	281;277;273	G;T;A	261;257;257	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1078	1080	ACT	287;291;293	A;C;T	269;270;276	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1084	1086	GAT	288;288;286	G;A;T	271;271;271	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1096	1098	CAC	281;280;280	C,T;A;C	264,1;263;265	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	1	SNP	p	G120K	1	.	.	358	360	AAG	561	563	CGG	291;291;283	C;G;G,A	269;266;261,1	porB1b.WHO_Z_02266c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	1	SNP	p	D121N	0	.	.	361	363	GAC	564	567	CGC	285;279;280	C;G,A;C,A	260;257,1;259,1	porB1b.WHO_Z_02266c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3480	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1394	247.3	1	SNP	p	A121D	1	.	.	361	363	GAC	564	567	CGC	285;279;280	C;G,A;C,A	260;257,1;259,1	porB1b.WHO_Z_02266c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	12348	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5029	245.1	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2108	2110	CAT	252;248;253	C;A;T	239;237;242	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1418	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1115	126.0	1	SNP	p	V57M	1	.	.	169	171	ATG	477	479	ATG	282;282;278	A;T;G	271;273;267	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
